scholarly article | Q13442814 |
P356 | DOI | 10.3109/00498259209053144 |
P698 | PubMed publication ID | 1455903 |
P2093 | author name string | E. Worth | |
H. R. Wiltshire | |||
K. J. Prior | |||
S. R. Harris | |||
U. M. Kozlowski | |||
P2860 | cites work | Tocainide conjugation in humans: novel biotransformation pathway for a primary amine | Q42271484 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolic pathway | Q68685 |
P304 | page(s) | 837-857 | |
P577 | publication date | 1992-07-01 | |
P1433 | published in | Xenobiotica | Q1360678 |
P1476 | title | Metabolism of calcium antagonist Ro 40-5967: a case history of the use of diode-array u.v. spectroscopy and thermospray-mass spectrometry in the elucidation of a complex metabolic pathway | |
P478 | volume | 22 |
Q71377756 | Effects of mibefradil on intracellular Ca2+ release in cultured rat cardiac fibroblasts and human platelets |
Q71795356 | High-performance liquid chromatographic analysis of mibefradil in dog plasma and urine |
Q43831406 | Interference of a carbamoyl glucuronide metabolite in quantitative liquid chromatography/tandem mass spectrometry |
Q73485500 | Metabolism of the calcium antagonist, mibefradil (POSICORTM, Ro 40-5967). Part III. Comparative pharmacokinetics of mibefradil and its major metabolites in rat, marmoset, cynomolgus monkey and man |
Q93899050 | Metabolism of the calcium antagonist, mibefradil (POSICORâ„¢, Ro 40-5967). Part II. Metabolism in hepatic microsomes from rat, marmoset, cynomolgus monkey, rabbit and man |
Q34082998 | The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil |
Q43743505 | Use of on-line hydrogen/deuterium exchange to facilitate metabolite identification |